Article Data

  • Views 207
  • Dowloads 3

Original Research

Open Access

Risk factors for developing epilepsy after neonatal seizures


1,Clinical Department of Neonatology Division of Paediatrics University Medical Centre Ljubljana

2Clinical Department of Child, Adolescent and Developmental Neurology Division of Paediatrics University Medical Centre Ljubljana

DOI: 10.22514/SV91.042014.6 Vol.9,Issue 1,April 2014 pp.37-41

Published: 30 April 2014

*Corresponding Author(s): DARJA PARO-PANJAN E-mail:


Neonatal seizures are the most frequent neurological disorder in the neonatal period. The incidence is reported to be higher than at any other period in life. Because of the unique nature of neonatal brain anatomy, connections and the paradoxical nature of neurotransmitters, seizures in this age group vary in semiology from those in older children. They may cause irreversible changes to the synapses in the immature brain and progress to epilepsy. 

The aim of the study was to analyse laboratory, clinical, neurophysiological and neuroimaging risk factors for epilepsy in a group of children who experienced seizures in the neonatal period.

A retrospective study of 176 newborns admitted to the Department of Neonatology, University Children’s Hospital Ljubljana, due to seizures, was performed. Metabolic disorders and hypoxic-ischaemic encephalopathy were the most frequent aeti-ological factors associated with seizures. Epilepsy rate in the group was 18%. Pathological cardiotocography, reanimation after delivery, myoclonic type of seizures, more than one type of seizures, severely abnormal electroencephalography, abnormal neurological examination and neuroimaging, treatment with more than one antiepileptic drug and duration of treatment more than one month constituted statistically significant independent predictive factors for epilepsy (p< 0.05). The results of our study further elucidate risk factors for epilepsy after neonatal seizures.


newborns, seizures, epi-lepsy, risk factors

Cite and Share

ANETA SOLTIROVSKA ŠALAMON ,DAVID NEUBAUER,DARJA PARO-PANJAN. Risk factors for developing epilepsy after neonatal seizures. Signa Vitae. 2014. 9(1);37-41.


1. Volpe JJ. Neonatal seizures. In: Neurology of the newborn. 5th ed. Philadelphia. WB  Saunders; 2001. p. 203-44.

2. Clancy RR. Summary proceeding from the Neurology Group on neonatal seizures. Pediatrics 2006;117:S23-7.

3. Isaeva E, Isaev D, Savrasova A, Khazipov R, Holmes GL. Recurrent neonatal seizures result in long-term increases in neuronal network excitability in the rat neocortex. Eur J Neurosci 2010;31:1446–55.

4. Holmes GL. Effects of seizures on brain development: Lessons from laboratory. Pediatr Neurol 2005;33:1-11.

5. Holden KR, Mellits D, Freeman JM. Neonatal seizures I: correlation of prenatal and perinatal events with outcome. Pediatrics 1982;70:165-76.

6. Ronen GM, Buckley D, Penney S, Streiner DL. Long-term prognosis in children with neonatal seizures: a population based study. Neurology 2007;69:1816-22.

7. Garfinkle J, Shevell MI. Cerebral palsy, developmental delay, and epilepsy after neonatal seizures. Pediatr Neurol 2011; 44: 88-96.

8. Mizrahi EM, Kellaway P. Characterization and classification of neonatal seizures. Neurology 1987;37:1837-44.

9. Tekgul H, Gauvreau K, Soul J. Murphy L, Robertson R, Stewart J, et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics 2006;117:1270–80.

10. Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia 1991;32:69-76.

11. Holmes GL, Lombroso CT. Prognostic value of background patterns in the neonatal EEG. J Clin Neurophysiol 1993;10(3):323-52.

12. Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia 1991;32:69–76.

13. Almubarak S, Wong PK. Long-term clinical outcome of neonatal EEG findings. J Clin Neurophysiol 2011;28(2):185-9.

14. Ronen GM, Buckley D, Penney S, Streiner DL. Long-term prognosis in children with neonatal seizures: a population-based study. Neuro-logy 2007;69:1816–22.

15. Guillet R, Kwon J. Seizure recurrence and developmental disabilities after neonatal seizures: outcomes are unrelated to use of phenobar-bital prophylaxis. J Child Neurol 2007;22:389–95.

16. Biagioni E, Ferrari F, Boldrini A, Roversi MF, Cioni G. Prediction of outcome based on clinical seizure type in newborn infants. J Pediatr 2002;140:707–12.

17. Glass HC, Glidden D, Jeremy RJ, Barkovich AJ, Ferriero DM, Miller SP. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediat. 2009;155:318–23.

18. Miller SP, Weiss J, Barnwell A, Ferriero DM, Latal-Hajnal B, Ferrer-Rogers A, et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002;52:542-8.

19. Garfinkle J, Shevell MI. Prognostic factors and development of a scoring system for outcome of neonatal seizures in term infants. EJP Neurology 2011;15:222-9.

20. Dudek FE, Ekstrand JJ, Staley KJ. Is neuronal death necessary for acquired epileptogenesis in the immature brain? Epilepsy Curr 2010;10:95-9.

21. Amiel-Tison C. Update of the Amiel-Tison neurologic assessment for the term neonate or at 40 weeks corrected age. Pediatr Neurol 2002;15:196–212.

22. Paro-Panjan D, Neubauer D, Kodric J, Bratanic B. Amiel-Tison Neurological assessment at term age clinical application, correlation with other methods, and outcome at 12 to15 months. Dev Med Child Neurol 2005 Jan;47(1):19-26.

23. Khan PL, Nunes ML, Gardas de Silva LF, Costa de Costa J. Predictive value of sequential electroencephalogram in neonates with seizures and its relation to neurological outcome. J Child Neurol 2008;23:144-50.

24. Shewmon DA. What is neonatal seizure? Problems in definition and quantification for investigative and clinical purposes. J Clin Neurophy-siol 1990;7:315-68.

25. Paro-Panjan D, Neubauer D, Kodric J, Bratanic B. Electroclinical correlation in neonatal seizures. Eur J Paediatr Neurol 1998;2:117-25.

26. Aicardi J, Goutrieres F. Encephalopathie myoclonique neonatal. Rev Electroencephalogr Neurophysiol Clin 1978;8:99-101.

27. Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008;122(1):65-74.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time